866-997-4948(US-Canada Toll Free)

Global Therapeutic Nuclear Medicines Sales Market Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 106 Pages

In this report, the global Therapeutic Nuclear Medicines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Therapeutic Nuclear Medicines for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Therapeutic Nuclear Medicines market competition by top manufacturers/players, with Therapeutic Nuclear Medicines sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
Cardinal Health
Mallkrodt Plc
GE Healthcare
Lantheus Medical Imaging
Bayer AG
Bracco Imaging SpA
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications SA
IBA Molecular Imaging
On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
Beta Emitters Therapeutic Nuclear Medicines
Alpha Emitters Therapeutic Nuclear Medicines
Brachytherapy Therapeutic Nuclear Medicines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Therapeutic Nuclear Medicines for each application, including
Hospitals
Ambulatory Surgical Centers
Other

Table of Contents

Global Therapeutic Nuclear Medicines Sales Market Report 2017
1 Therapeutic Nuclear Medicines Market Overview
1.1 Product Overview and Scope of Therapeutic Nuclear Medicines
1.2 Classification of Therapeutic Nuclear Medicines by Product Category
1.2.1 Global Therapeutic Nuclear Medicines Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Therapeutic Nuclear Medicines Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Beta Emitters Therapeutic Nuclear Medicines
1.2.4 Alpha Emitters Therapeutic Nuclear Medicines
1.2.5 Brachytherapy Therapeutic Nuclear Medicines
1.3 Global Therapeutic Nuclear Medicines Market by Application/End Users
1.3.1 Global Therapeutic Nuclear Medicines Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Other
1.4 Global Therapeutic Nuclear Medicines Market by Region
1.4.1 Global Therapeutic Nuclear Medicines Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Therapeutic Nuclear Medicines Status and Prospect (2012-2022)
1.4.3 China Therapeutic Nuclear Medicines Status and Prospect (2012-2022)
1.4.4 Europe Therapeutic Nuclear Medicines Status and Prospect (2012-2022)
1.4.5 Japan Therapeutic Nuclear Medicines Status and Prospect (2012-2022)
1.4.6 Southeast Asia Therapeutic Nuclear Medicines Status and Prospect (2012-2022)
1.4.7 India Therapeutic Nuclear Medicines Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Therapeutic Nuclear Medicines (2012-2022)
1.5.1 Global Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2022)
1.5.2 Global Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2022)

2 Global Therapeutic Nuclear Medicines Competition by Players/Suppliers, Type and Application
2.1 Global Therapeutic Nuclear Medicines Market Competition by Players/Suppliers
2.1.1 Global Therapeutic Nuclear Medicines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Therapeutic Nuclear Medicines Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Therapeutic Nuclear Medicines (Volume and Value) by Type
2.2.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Type (2012-2017)
2.2.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2012-2017)
2.3 Global Therapeutic Nuclear Medicines (Volume and Value) by Region
2.3.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Region (2012-2017)
2.3.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Region (2012-2017)
2.4 Global Therapeutic Nuclear Medicines (Volume) by Application

3 United States Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
3.1 United States Therapeutic Nuclear Medicines Sales and Value (2012-2017)
3.1.1 United States Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
3.1.2 United States Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
3.1.3 United States Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
3.2 United States Therapeutic Nuclear Medicines Sales Volume and Market Share by Players
3.3 United States Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
3.4 United States Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

4 China Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
4.1 China Therapeutic Nuclear Medicines Sales and Value (2012-2017)
4.1.1 China Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
4.1.2 China Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
4.1.3 China Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
4.2 China Therapeutic Nuclear Medicines Sales Volume and Market Share by Players
4.3 China Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
4.4 China Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

5 Europe Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
5.1 Europe Therapeutic Nuclear Medicines Sales and Value (2012-2017)
5.1.1 Europe Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
5.1.2 Europe Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
5.1.3 Europe Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
5.2 Europe Therapeutic Nuclear Medicines Sales Volume and Market Share by Players
5.3 Europe Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
5.4 Europe Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

6 Japan Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
6.1 Japan Therapeutic Nuclear Medicines Sales and Value (2012-2017)
6.1.1 Japan Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
6.1.2 Japan Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
6.1.3 Japan Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
6.2 Japan Therapeutic Nuclear Medicines Sales Volume and Market Share by Players
6.3 Japan Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
6.4 Japan Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

7 Southeast Asia Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
7.1 Southeast Asia Therapeutic Nuclear Medicines Sales and Value (2012-2017)
7.1.1 Southeast Asia Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
7.2 Southeast Asia Therapeutic Nuclear Medicines Sales Volume and Market Share by Players
7.3 Southeast Asia Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
7.4 Southeast Asia Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

8 India Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
8.1 India Therapeutic Nuclear Medicines Sales and Value (2012-2017)
8.1.1 India Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
8.1.2 India Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
8.1.3 India Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
8.2 India Therapeutic Nuclear Medicines Sales Volume and Market Share by Players
8.3 India Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
8.4 India Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

9 Global Therapeutic Nuclear Medicines Players/Suppliers Profiles and Sales Data
9.1 Cardinal Health
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Cardinal Health Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Mallkrodt Plc
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Mallkrodt Plc Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 GE Healthcare
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 GE Healthcare Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Lantheus Medical Imaging
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Bayer AG
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Bayer AG Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Bracco Imaging SpA
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Bracco Imaging SpA Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Eczacibasi-Monrol Nuclear Products
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Nordion
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Nordion Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Advanced Accelerator Applications SA
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 IBA Molecular Imaging
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 IBA Molecular Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview

10 Therapeutic Nuclear Medicines Maufacturing Cost Analysis
10.1 Therapeutic Nuclear Medicines Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines
10.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Therapeutic Nuclear Medicines Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Therapeutic Nuclear Medicines Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Therapeutic Nuclear Medicines Market Forecast (2017-2022)
14.1 Global Therapeutic Nuclear Medicines Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Therapeutic Nuclear Medicines Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Therapeutic Nuclear Medicines Price and Trend Forecast (2017-2022)
14.2 Global Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Therapeutic Nuclear Medicines Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Therapeutic Nuclear Medicines Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Therapeutic Nuclear Medicines Sales Forecast by Type (2017-2022)
14.3.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Type (2017-2022)
14.3.3 Global Therapeutic Nuclear Medicines Price Forecast by Type (2017-2022)
14.4 Global Therapeutic Nuclear Medicines Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Therapeutic Nuclear Medicines
Figure Global Therapeutic Nuclear Medicines Sales Volume Comparison (MT) by Type (2012-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume Market Share by Type (Product Category) in 2016
Figure Beta Emitters Therapeutic Nuclear Medicines Product Picture
Figure Alpha Emitters Therapeutic Nuclear Medicines Product Picture
Figure Brachytherapy Therapeutic Nuclear Medicines Product Picture
Figure Global Therapeutic Nuclear Medicines Sales Comparison (MT) by Application (2012-2022)
Figure Global Sales Market Share of Therapeutic Nuclear Medicines by Application in 2016
Figure Hospitals Examples
Figure Ambulatory Surgical Centers Examples
Figure Other Examples
Figure Global Therapeutic Nuclear Medicines Market Size (Million USD) by Regions (2012-2022)
Figure United States Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume (MT) and Growth Rate (2012-2022)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Therapeutic Nuclear Medicines Sales Volume (MT) (2012-2017)
Table Global Therapeutic Nuclear Medicines Sales (MT) of Key Players/Suppliers (2012-2017)
Table Global Therapeutic Nuclear Medicines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Therapeutic Nuclear Medicines Sales Share by Players/Suppliers
Figure 2017 Therapeutic Nuclear Medicines Sales Share by Players/Suppliers
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Therapeutic Nuclear Medicines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Therapeutic Nuclear Medicines Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Therapeutic Nuclear Medicines Revenue Share by Players
Table 2017 Global Therapeutic Nuclear Medicines Revenue Share by Players
Table Global Therapeutic Nuclear Medicines Sales (MT) and Market Share by Type (2012-2017)
Table Global Therapeutic Nuclear Medicines Sales Share (MT) by Type (2012-2017)
Figure Sales Market Share of Therapeutic Nuclear Medicines by Type (2012-2017)
Figure Global Therapeutic Nuclear Medicines Sales Growth Rate by Type (2012-2017)
Table Global Therapeutic Nuclear Medicines Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Therapeutic Nuclear Medicines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Therapeutic Nuclear Medicines by Type (2012-2017)
Figure Global Therapeutic Nuclear Medicines Revenue Growth Rate by Type (2012-2017)
Table Global Therapeutic Nuclear Medicines Sales Volume (MT) and Market Share by Region (2012-2017)
Table Global Therapeutic Nuclear Medicines Sales Share by Region (2012-2017)
Figure Sales Market Share of Therapeutic Nuclear Medicines by Region (2012-2017)
Figure Global Therapeutic Nuclear Medicines Sales Growth Rate by Region in 2016
Table Global Therapeutic Nuclear Medicines Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Therapeutic Nuclear Medicines Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Therapeutic Nuclear Medicines by Region (2012-2017)
Figure Global Therapeutic Nuclear Medicines Revenue Growth Rate by Region in 2016
Table Global Therapeutic Nuclear Medicines Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Therapeutic Nuclear Medicines Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Therapeutic Nuclear Medicines by Region (2012-2017)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Region in 2016
Table Global Therapeutic Nuclear Medicines Sales Volume (MT) and Market Share by Application (2012-2017)
Table Global Therapeutic Nuclear Medicines Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Therapeutic Nuclear Medicines by Application (2012-2017)
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Application (2012-2017)
Figure United States Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure United States Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Therapeutic Nuclear Medicines Sales Price (USD/MT) Trend (2012-2017)
Table United States Therapeutic Nuclear Medicines Sales Volume (MT) by Players (2012-2017)
Table United States Therapeutic Nuclear Medicines Sales Volume Market Share by Players (2012-2017)
Figure United States Therapeutic Nuclear Medicines Sales Volume Market Share by Players in 2016
Table United States Therapeutic Nuclear Medicines Sales Volume (MT) by Type (2012-2017)
Table United States Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2012-2017)
Figure United States Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2016
Table United States Therapeutic Nuclear Medicines Sales Volume (MT) by Application (2012-2017)
Table United States Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2012-2017)
Figure United States Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2016
Figure China Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure China Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Therapeutic Nuclear Medicines Sales Price (USD/MT) Trend (2012-2017)
Table China Therapeutic Nuclear Medicines Sales Volume (MT) by Players (2012-2017)
Table China Therapeutic Nuclear Medicines Sales Volume Market Share by Players (2012-2017)
Figure China Therapeutic Nuclear Medicines Sales Volume Market Share by Players in 2016
Table China Therapeutic Nuclear Medicines Sales Volume (MT) by Type (2012-2017)
Table China Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2012-2017)
Figure China Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2016
Table China Therapeutic Nuclear Medicines Sales Volume (MT) by Application (2012-2017)
Table China Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2012-2017)
Figure China Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2016
Figure Europe Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Sales Price (USD/MT) Trend (2012-2017)
Table Europe Therapeutic Nuclear Medicines Sales Volume (MT) by Players (2012-2017)
Table Europe Therapeutic Nuclear Medicines Sales Volume Market Share by Players (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Sales Volume Market Share by Players in 2016
Table Europe Therapeutic Nuclear Medicines Sales Volume (MT) by Type (2012-2017)
Table Europe Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2016
Table Europe Therapeutic Nuclear Medicines Sales Volume (MT) by Application (2012-2017)
Table Europe Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2016
Figure Japan Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Japan Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Therapeutic Nuclear Medicines Sales Price (USD/MT) Trend (2012-2017)
Table Japan Therapeutic Nuclear Medicines Sales Volume (MT) by Players (2012-2017)
Table Japan Therapeutic Nuclear Medicines Sales Volume Market Share by Players (2012-2017)
Figure Japan Therapeutic Nuclear Medicines Sales Volume Market Share by Players in 2016
Table Japan Therapeutic Nuclear Medicines Sales Volume (MT) by Type (2012-2017)
Table Japan Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2012-2017)
Figure Japan Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2016
Table Japan Therapeutic Nuclear Medicines Sales Volume (MT) by Application (2012-2017)
Table Japan Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2012-2017)
Figure Japan Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2016
Figure Southeast Asia Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Southeast Asia Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Therapeutic Nuclear Medicines Sales Price (USD/MT) Trend (2012-2017)
Table Southeast Asia Therapeutic Nuclear Medicines Sales Volume (MT) by Players (2012-2017)
Table Southeast Asia Therapeutic Nuclear Medicines Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Therapeutic Nuclear Medicines Sales Volume Market Share by Players in 2016
Table Southeast Asia Therapeutic Nuclear Medicines Sales Volume (MT) by Type (2012-2017)
Table Southeast Asia Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2016
Table Southeast Asia Therapeutic Nuclear Medicines Sales Volume (MT) by Application (2012-2017)
Table Southeast Asia Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2016
Figure India Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure India Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Therapeutic Nuclear Medicines Sales Price (USD/MT) Trend (2012-2017)
Table India Therapeutic Nuclear Medicines Sales Volume (MT) by Players (2012-2017)
Table India Therapeutic Nuclear Medicines Sales Volume Market Share by Players (2012-2017)
Figure India Therapeutic Nuclear Medicines Sales Volume Market Share by Players in 2016
Table India Therapeutic Nuclear Medicines Sales Volume (MT) by Type (2012-2017)
Table India Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2012-2017)
Figure India Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2016
Table India Therapeutic Nuclear Medicines Sales Volume (MT) by Application (2012-2017)
Table India Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2012-2017)
Figure India Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2016
Table Cardinal Health Basic Information List
Table Cardinal Health Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Cardinal Health Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Cardinal Health Therapeutic Nuclear Medicines Sales Global Market Share (2012-2017
Figure Cardinal Health Therapeutic Nuclear Medicines Revenue Global Market Share (2012-2017)
Table Mallkrodt Plc Basic Information List
Table Mallkrodt Plc Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Mallkrodt Plc Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Mallkrodt Plc Therapeutic Nuclear Medicines Sales Global Market Share (2012-2017
Figure Mallkrodt Plc Therapeutic Nuclear Medicines Revenue Global Market Share (2012-2017)
Table GE Healthcare Basic Information List
Table GE Healthcare Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GE Healthcare Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure GE Healthcare Therapeutic Nuclear Medicines Sales Global Market Share (2012-2017
Figure GE Healthcare Therapeutic Nuclear Medicines Revenue Global Market Share (2012-2017)
Table Lantheus Medical Imaging Basic Information List
Table Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales Global Market Share (2012-2017
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Revenue Global Market Share (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bayer AG Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Bayer AG Therapeutic Nuclear Medicines Sales Global Market Share (2012-2017
Figure Bayer AG Therapeutic Nuclear Medicines Revenue Global Market Share (2012-2017)
Table Bracco Imaging SpA Basic Information List
Table Bracco Imaging SpA Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bracco Imaging SpA Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Bracco Imaging SpA Therapeutic Nuclear Medicines Sales Global Market Share (2012-2017
Figure Bracco Imaging SpA Therapeutic Nuclear Medicines Revenue Global Market Share (2012-2017)
Table Eczacibasi-Monrol Nuclear Products Basic Information List
Table Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales Global Market Share (2012-2017
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Revenue Global Market Share (2012-2017)
Table Nordion Basic Information List
Table Nordion Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Nordion Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Nordion Therapeutic Nuclear Medicines Sales Global Market Share (2012-2017
Figure Nordion Therapeutic Nuclear Medicines Revenue Global Market Share (2012-2017)
Table Advanced Accelerator Applications SA Basic Information List
Table Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales Global Market Share (2012-2017
Figure Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Revenue Global Market Share (2012-2017)
Table IBA Molecular Imaging Basic Information List
Table IBA Molecular Imaging Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Sales Growth Rate (2012-2017)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Sales Global Market Share (2012-2017
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Therapeutic Nuclear Medicines
Figure Manufacturing Process Analysis of Therapeutic Nuclear Medicines
Figure Therapeutic Nuclear Medicines Industrial Chain Analysis
Table Raw Materials Sources of Therapeutic Nuclear Medicines Major Players in 2016
Table Major Buyers of Therapeutic Nuclear Medicines
Table Distributors/Traders List
Figure Global Therapeutic Nuclear Medicines Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Therapeutic Nuclear Medicines Price (USD/MT) and Trend Forecast (2017-2022)
Table Global Therapeutic Nuclear Medicines Sales Volume (MT) Forecast by Regions (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume Market Share Forecast by Regions in 2022
Table Global Therapeutic Nuclear Medicines Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Regions in 2022
Figure United States Therapeutic Nuclear Medicines Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Therapeutic Nuclear Medicines Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure China Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Therapeutic Nuclear Medicines Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Europe Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Therapeutic Nuclear Medicines Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Japan Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Therapeutic Nuclear Medicines Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Therapeutic Nuclear Medicines Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure India Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Therapeutic Nuclear Medicines Sales (MT) Forecast by Type (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Therapeutic Nuclear Medicines Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Type (2017-2022)
Table Global Therapeutic Nuclear Medicines Price (USD/MT) Forecast by Type (2017-2022)
Table Global Therapeutic Nuclear Medicines Sales (MT) Forecast by Application (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *